Milan, Italy

Annibale Salvi

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2003-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Annibale Salvi

Introduction

Annibale Salvi is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on lipoic acid. With a total of 10 patents to his name, Salvi's work has advanced the development of new therapeutic formulations.

Latest Patents

Among his latest patents, Salvi has developed a unique lipoic acid pellet composition. This invention concerns a new formulation based on pellets of lipoic acid in a lipophilic medium, which can be combined with other active ingredients if necessary. Additionally, he has described lipoic acid pellets that are obtained from inert cores coated with lipoic acid. These active cores are further coated with a layer of insulating polymeric material and then with a polymeric coat that is insoluble at gastric pH. The resulting pellets can be formulated pharmaceutically into various forms, such as jelly capsules, controlled release capsules, oral suspensions, dispersible powders, and sachets.

Career Highlights

Salvi has worked with prominent companies in the pharmaceutical industry, including Laboratorio Chimico Internazionale S.p.a. and Olon S.p.a. His experience in these organizations has allowed him to refine his expertise in drug formulation and innovation.

Collaborations

Throughout his career, Salvi has collaborated with notable professionals, including Antonio Nardi and Flavio Villani. These partnerships have contributed to the successful development of his patented inventions.

Conclusion

Annibale Salvi's innovative work in the field of pharmaceutical compositions, particularly with lipoic acid, showcases his dedication to advancing medical science. His numerous patents reflect his commitment to improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…